SEC Form 5 · accession 0001570523-18-000009
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 31, 2017
Accepted (ET)
Mar 29, 2018 · 8:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 22, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 22, 2017 | P | 22,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 24, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 28, 2017 | P | 10,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Nov 29, 2017 | P | 5,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Nov 29, 2017 | P | 5,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Nov 29, 2017 | P | 10,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Nov 30, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Nov 30, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 1, 2017 | P | 100,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 1, 2017 | P | 20,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 1, 2017 | P | 50,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 30,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 10,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 20,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 20,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 10,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 40,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 24,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 5, 2017 | P | 10,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 6, 2017 | P | 16,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 6, 2017 | P | 5,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 6, 2017 | P | 2,000 | $0.02 | A | 22,059,859 | D | |
| Common stock | Dec 13, 2017 | P | 5,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 15, 2017 | P | 5,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 19, 2017 | P | 20,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Dec 19, 2017 | P | 50,000 | $0.01 | A | 22,059,859 | D | |
| Common stock | Jan 4, 2016 | P | 500 | $0.19 | A | 20,800,359 | D | |
| Common stock | Jan 4, 2016 | P | 500 | $0.19 | A | 20,800,359 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This is part 5 of 16 submissions.